Radioactive dye holds promise for Alzheimer's detection

08/22/2008 | Bloomberg

U.S. scientists developed a radioactive dye called Pittsburgh Compound B that can detect Alzheimer's disease on an imaging device by binding to amyloid -- proteins linked to the condition. Backed by General Electric, the dye could help with early detection of the disease and aid drugmakers in assessing their products' efficacy in treating brain damage. Researchers are testing the dye in Alzheimer's patients with symptoms such as forgetfulness and disorientation.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ